Clinical Trial Update: Prognostic Value of Early Postoperative Prostate-Specific Antigen for Oncological Outcomes After Radical Prostatectomy

View source ↗

Summary

A clinical trial update indicates the study on the prognostic value of early postoperative PSA for oncological outcomes after radical prostatectomy is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Lithuanian University of Health Sciences | Conditions: Prostate Cancer (Post Prostatectomy), Prostate Cancer (Adenocarcinoma) | Status: RECRUITING